Home About Us Emgen Registration Contact Us Ask Your Scientific Question Answer to your Question Idea and Suggestion Photo Gallery
 
Home
Members
Membership
Director
Steering Committee
News
EMGEN News
Focal Points
Training
MOUs
Reports
Webinar
Facilities and Services
Newsletter
Articles
Journals
Publications
Job Opprtunities
Other Links
Scientists Database
 
  biotech-27
NAMEMISSIONSTRATEGIES
U.S.A.Manoa Asia-Pacific Institute of Tropical Medicine and Infectious Diseases (APITMID) Duane J. Gubler, ScD
Director, Asia-Pacific Institute of Tropical Medicine and Infectious Diseases
Professor & Chair, Department of Tropical Medicine and Medical Microbiology
John A. Burns School of Medicine
University of Hawaii at Manoa
651 Ilalo Street, BSB 3rd Floor
Honolulu, HI 96813
Tel: (808) 692-1606
FAX: (808) 732-1483
e-mail: dgubler@hawaii.edu
 
To develop a balanced, transdisciplinary research program that focuses on basic, translational, and field research on microbial diseases of public health importance in the Asia-Pacific region.

Collectively, past and current research and training programs in tropical medicine, public health, microbiology and immunology at the University of Hawaii at Manoa provide a unique platform on which to build a world-class institute for tropical medicine and infectious diseases that focuses specifically on the Asia-Pacific region. Asia-Pacific Institute of Tropical Medicine and Infectious Diseases (APITMID), will work to meet the growing challenge of understanding, preventing and controlling the dramatic global re-emergence of infectious diseases in the Asia-Pacific region.

During the past 25 years, infectious diseases have once again regained their position as the leading cause of morbidity and mortality worldwide. The developing countries of the tropical Asia-Pacific region have been among those geographic areas hardest hit by this resurgence. Thus, infectious diseases are among the most important public health and economic problems facing the Asian-Pacific region at the beginning of the new millennium. In particular, “old diseases”, such as dengue/dengue hemorrhagic fever, epidemic polyarthritis, Japanese encephalitis, malaria, cholera, tuberculosis, plague and influenza, have repeatedly caused major epidemics in the region, and have severely taxed the public health infrastructure and the economies in many of these countries. In addition, the emergence of newly recognized pathogens such as human immunodeficiency virus, Nipah virus, Hendra virus, SARS corona virus and avian influenza virus, all of which are zoonotic viruses that have “jumped species”, have caused major epidemics in recent years that have resulted in significant loss of human lives and devastating economic consequences worldwide.

The myriad factors responsible for this alarming global re-emergence of infectious diseases are not fully understood, but it is clear that global demographic and societal changes have been primarily contributory. The unprecedented population growth since World War II has been one of the principal driving forces behind the uncontrolled urbanization and human migration patterns. This, combined with the rapid and massive movement of people, animals (with their endo-and ecto-parasites) and commodities via jet air travel and other modes of modern transportation, along with the insidious breakdown of the public health infrastructure to deal with infectious diseases, and the long-held emphasis on curative rather than preventive medicine, have all contributed to the resurgence of infectious diseases.

All of the global public health emergencies in the past 10 years, have originated in Asia, i.e., plague in India, 1994; Hong Kong Flu, 1997; Nipah encephalitis, 1999; SARS, 2003; and avian influenza, 2004. This trend makes it imperative that programs be established to monitor infectious diseases in this region using the most modern laboratory and epidemiologic technology. By virtue of its strategic geographic location as the gateway to/from Asia and the Pacific Islands, and its strong ties to resource-poor developing countries in that region, the University of Hawaii at Manoa is in a position to rapidly develop the capacity to fill this niche. That is, the University of Hawaii at Manoa has a long history of training students and public health officers from Asia and the Pacific in medicine and public health; many of these former graduates are now in high-level administrative positions in ministries of health and/or in upper level professorial positions at universities throughout Asia. In addition, the University of Hawaii at Manoa has close cultural ties to Asia and the Pacific, and over the years, has developed close working relationships and strong partnerships based on mutual trust, with institutions in the region. Finally, the East-West Center provides an expanded dimension to these ties with Asia
 
The Asia-Pacific Institute is being developed in several phases.

Phase I
This phase will focus on developing partnerships, recruiting faculty and staff, establishing priority research areas and obtaining funding. The Institute will be staffed by existing UH faculty and new hires that will be brought in over a period of 5 years. Administratively, APITMID is located in the medical school, but staff will represent a number of other administrative units within and from outside the University. These include:

University of Hawaii at Manoa
John A. Burns School of Medicine
Department of Tropical Medicine, Medical Microbiology and Pharmacology
Department of Public Health Sciences and Epidemiology
Department of Cell and Molecular Biology
Department of Medicine
Department of Pediatrics
Pacific Biomedical Research Center
Cancer Research Center of Hawaii
College of Natural Sciences
College of Social Sciences
College of Engineering
School of Ocean and Earth Science Technology

State Department of Health
Division of Disease Outbreak Control
Division of Communicable Diseases
State Division of Laboratories

East-West Center
Hawaii Biotech, Inc.
Maui High-Performance Computing Center

Department of Defense
U.S. Pacific Command
Tripler Army Medical Center
U.S. Navy Preventive Medicine Unit No. 6


Involvement of programs and individuals from the above organizations are based on interest and expertise; selected individuals with specific expertise within the local research community will be actively recruited to join the new Institute.

International partners will include U.S. Government laboratories in Thailand and Indonesia, and institutions in Viet Nam, and other selected countries in the Asia-Pacific Region.

A major partner in this initiative is the State of Hawaii, which has completed building a $150 million medical school campus at Kaka`ako. APITMID occupies the third floor of the biosciences research building, approximately 41,000 square feet of state-of-the art laboratory and animal space.

Six centers constitute the initial anchors for the APITMID programs. The Pacific Center for AIDS Research is Directed by Dr. Cecilia Shikuma, and is already well funded, and includes the Hawaii AIDS Clinical Trial Unit, and the University of Hawaii NeuroAIDS Specialized Neuroscience Research Program. Funding for these programs and other AIDS-related research projects already exceed $4.5 million per year in direct costs.

The Pacific Center for Emerging Infectious Disease Research, directed by Dr. Richard Yanagihara, has recently received a $9.6 million COBRE grant from NIH. The Asia-Pacific Center for Infectious Disease Ecology Research, directed by Dr. Bruce Wilcox and the Asia-Pacific Center for Biosecurity, Disater and Conflict Research, directed by Dr. Fredrick Burkle have only recently been formed. Funding proposals for these two centers are in progress.

Phase II
The emphasis in Phase II will be to develop basic and applied research programs for each of the initial anchor centers. Simultaneously, the Department of Tropical Medicine and Medical Microbiology graduate program will be expanded and improved to attract highly motivated, research-oriented doctoral degree candidates to participate in the research conducted by Institute scientists. In addition, field sites in Asia and the Pacific will be identified to conduct field research, and to train students and faculty, as well as for product testing and evaluation. These field sites will be instrumental in attracting partnerships with other universities and with private industry to test and evaluate newly developed biomedical products.


FAULTY MEMBERPROGRAMS
ALIMINETI, Kavitha B.Tech, MSARAI, Satoru PhDBENNETT, Shannon PhDBERESTECKY, John M. PhDBERG, John T. PhDBESSINGER, Glenn PhDBESSINGER, Ruth PhDBirth-Melander, Pollie PhDBOMGAARS, Mona R. MDBURKLE, Jr. Frederick M. MD, MPHCHANG, Sandra PhDCOLLIER, Abby C. PhDCROPP, C. Bruce MSDIWAN, Arwind PhDEFFLER, Paul MD, MPHEFIRD, Jimmy Thomas PhDERDEM, Guliz MDFURUSAWA, Eiichi MD, PhDGOSNELL, William PhDGUBLER, Duane J. ScDHiratsuka, NatalieHong, Mi-Kyung, MPH HUI, George S.N. PhDIMRIE, Allison PhDJOURDAN-LE SAUX, ClaudeKANESHIRO, Kenneth Y. PhDKAPAN, Durrell PhDKAUFUSI, Pakieli H. PhDKIM, Anne PhDKIM, Jerome MDKIMATA, Chieko RN, MPHKRAMER, Kenton PhDLEWIS, Michael PhDLU, Yuanan, PhDLUM, Bert MD, PhDMADDOCK, Jay PhDMELISH, Marian E. MDMILLER, F. DeWolfe MPH, PhDMIYAHARA, James PhDMOCZ, Gabor PhDNERURKAR, Vivek PhDOchner, Margaret MPHPIEN, Frank D. MDRATTO-KIM, Silvia PhDREAD, George PhDRUDOY, Raul C. MDSHIKUMA, Cecilia MDSHIRAMIZU, BruceSONG, Jin-Won MD PhDTAM, Elizabeth K. MDTAM, Leslie PhDTAYLOR, Diane PhDTICE, D. Alan MD, FACP VERMA, Saguna PhDWATANABE, Cori MBAWILCOX, Bruce PhDYAMADA, Seiji MD, MPHYAMAGA, Karen PhDYANAGIHARA, Richard MD, MPH  YOUNG LESLIE, Heather PhD      

The Asia-Pacific Institute consists of the following centers and core programs.

Pacific Center for AIDS Research 

focuses on clinical trials to evaluate new drugs and vaccines, with laboratory and field research in Hawaii and Thailand.
( Director, Dr. Cecilia Shikuma)

Pacific Center for Emerging Infectious Disease Research 

involves basic laboratory research in Hawaii combined with field epidemiologic research in Vietnam and Thailand, initially, and in other countries in the future.
(Director, Dr. Richard Yanagihara)

Asia-Pacific Center for Infectious Disease Ecology 

focuses on disease ecology, and integrative research addressing the interactions between social and ecological factors, including the relationship of anthropogenic environmental change, climate variability, and other environmental as well as human factors influencing pathogen transmission and evolution.
(Director, Dr. Bruce Wilcox)

Asia-Pacific Center for Biosecurity, Disaster and Conflict Research 

focuses on partnering with the Departments of Defense and Homeland Security, the Hawaii Department of Health, and other agencies to develop laboratory and field research on bioterrorism, disaster management and related topics.
(Director, Dr. Frederick Burkle )


APITMID Research Core

Director, Dr. Jimmy Thomas Efird
Associate Director, Dr. Pollie Bith-Melander

Medical Statistics and Infectious Diseases Modeling Unit (RCMI)

provides assistance to APITMID researchers in 1) study development and implementation (e.g., research design, protocol development, sample size and power calculations, questionnaire construction, randomization, organization of data safety and monitoring boards), 2) statistical analysis (e.g., basic inferential statistics, multivariate analysis, binary and Poisson regression models, time-to-event models, non-parametric methods, group sequential boundary points, permutation based micro-array analysis), and 3) infectious diseases modeling (e.g., disease transmission models, vaccine efficacy models, vector control models).
(Head, Dr. Jimmy Thomas Efird)

Bioinformatics and Computational Biology Unit (COBRE) 

supports molecular genetic and bioinformatics research on microbial disease agents, with services from primer design, to phylogenetic analysis (e.g., migration, selection, and recombination) and protein structural prediction. Analyses also include quantitative genetics modeling (e.g., linkage analysis, segregation analysis, identity-by-descent, additive polygenic models, linkage disequilibrium, and haplotype phase prediction and inference).
(Head, Dr. Shannon Bennett)

Applications Programming and Systems Development Unit 

provides systems programming, database design/management and computerized graphics services to APITMID researchers including development of computerized data entry screens, programming of cross-validated fields, edit checks, SAS programming, software installation and customized systems development.
(Manager, Kavitha Alimineti)

Medical Anthropology and Outcomes Evaluation Unit 

provides advice to APITMID staff in the cultural and ethnographic aspects of research study design and health outcomes evaluation.
(Head, Dr. Heather Young Leslie)

Applied Evolutionary Ecology and Population Genetics Unit

models the complex interactions between organismal phenotype, ecology and genetics results in the evolution of emerging infectious diseases, invasive species and tropical biodiversity.
(Head, Dr. Durrell Kapan )

Imaging and Multimedia Science Unit

provides imaging and multimedia database for the future education and technology.
(Head, Chieko Kimata )

APITMID Medical Sciences
Director, Dr. Diane Taylor

Parasitology Program 

draws on techniques from the fields of cell biology, bioinformatics, molecular biology, immunology, genetics and ecology to study parasites which infect humans and the relationship between them.. These include unicellular organisms such as Plasmodium spp., the organism which causes malaria, Leishmania donovani, the organism which causes leishmaniasis and multicellular organisms such as Schistosoma spp., Wuchereria bancrotti and Necator americanus.
(Head, Dr. George Hui)

Pharmacology program

investigates the actions of drugs and chemicals on cells, tissues and the whole body. We research how drugs produce both beneficial and adverse effects including improving the way drugs are tested to give greater benefit in the treatment of disease. The cellular and chemical characteristics of diseases, syndromes and conditions are studied so that molecules may be designed specifically to alter or enhance these characteristics. The study of pharmacology requires understanding normal body functions (anatomy, biochemistry and physiology) and the disturbances that occur as well as an appreciation of the chemistry of compounds. Within the broader field of Pharmacology the lab focuses on two main areas: 1) metabolism and Pharmacokinetics and 2) reproductive pharmacology and toxicology.
(Head, Dr. Abby Collier )

Immunology Program 

studies the structure and function of the immune system, innate and acquired immunity, the bodily distinction of self from nonself, and laboratory techniques involving the interaction of antigens with specific antibodies.
(Head, Dr. Allison Imrie )

Molecular Biology Program 

studies the molecular basis of life processes, including cellular respiration, excretion, and reproduction. It deals specifically with the formation, structure, and function of macromolecules essential to life, such as nucleic acids and proteins, and especially with their role in cell replication, the transmission of genetic information, and the manipulation of DNA so that it can be sequenced or mutated.
(Head, Dr. Sandra Chang )

Microbiology Program 

studies microorganisms including eukaryotes such as fungi and protists, and prokaryotes such as bacteria, protozoa and viruses.
(Head, Dr. Karen Yamaga )

Virology Program
 

studies biological viruses, their structure and classification, their ways to infect and exploit cells to reproduce and cause disease, the techniques to isolate and culture them, and their potential uses in research and therapy.
(Head, TBA )
 

 
 
Forgot you password? Forgot Your username? Create an account

 
 
   
 

Home | About Us | Emgen Registration | Contact Us | Downloads | Emgen Forum | You Scientific Question | Photo Gallery
Copyright © 2009 Emhgbn Allright Reserved Design By Ecomiran